IRA Negotiation Changes: Pharma’s Focus Remains On Near-Term Legislative, Regulatory Options

Manufacturers still hope to advance legislation removing the “pill penalty” from the law, as well as changes they want included in the CMS guidance for the 2028 price implementation year.